ImmunityBio reports 700% revenue growth, expands approvals globally

Go back to ImmunityBio reports 700% revenue growth, expands approvals globally
(NASDAQ: IBRX) Delayed: 8.13 --0 (-0%)
Previous Close $8.13    52 Week High
Open $8.13    52 Week Low
Day High $8.13    P/E N/A 
Day Low $8.13    EPS
Volume 8,027